Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women

Clinical Drug Investigation

Volumn 21, Issue 10, 2001, Pages 715-726

  Abdel Hameed, I ^a   Ebid, M ^a   Shelton, M J ^a   Adams, J M ^a   Cordaro, J A ^a   Gugino, L J ^a   Maliszewski, M ^a   Colomaio, R ^a   Hewitt, R G ^a   Morse, G D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALFENTANIL; ALPRAZOLAM; AMIKACIN; CAFFEINE; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; ESTRADIOL; FERROUS SULFATE; FLUCONAZOLE; HYDROCORTISONE; IBUPROFEN; INDOCYANINE GREEN; KETOCONAZOLE; LOPERAMIDE; METHAQUALONE; METHYLPREDNISOLONE; MULTIVITAMIN; PENTAMIDINE; PHENAZONE; PHENYTOIN; PROGESTERONE; PYRIDOXINE; THEOPHYLLINE; TRIAZOLAM; ZIDOVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG HALF LIFE; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUTEAL PHASE; LYMPHOCYTE COUNT; MENSTRUAL CYCLE; PRIORITY JOURNAL;

EID: 0034761331     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121100-00006     Document Type: Article

References (49)

1. Influence of sex on drug kinetics in man
2. Biochemical basis of sex differences in drug metabolism
3. Sex related differences in drug disposition in man
4. Gender effects in pharmacokinetics and pharmacodynamics
5. Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs
6. Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers
7. Phenytoin pharmacokinetics in catamenial epilepsy
8. The influence of the menstrual cycle on the metabolism and clearance of methaqualone
9. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics
10. Sex differences in absorption kinetics of sodium salicylate
11. Influence of menstrual cycle and gender on alprazolam pharmacokinetics
12. Propranolol pharmacokinetics during the menstrual cycle
13. Pharmacokinetics and bioavailability of zidovudine in humans
14. Pharmacokinetic variability of zidovudine in HIV-infected individuals: Subgroup analysis and drug interactions
15. Prolonged but not diminished zidovudine (ZDV) absorption induced by a high fat breakfast
16. Zidovudine pharmacokinetics in HIV-positive women during different phases of the menstrual cycle
17. Radioimmunoassay of zidovudine: Extended use and potential application
18. Zidovudine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
19. Zidovudine: An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
20. Comparative pharmacokinetics of antiviral nucleoside analogues
21. Clinical pharmacokinetics of zidovudine: An overview of current data
22. Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents
23. Clinical pharmacokinetics of zidovudine: An update
24. Pharmacokinetics of zidovudine during pregnancy
25. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants
26. Status of research on gender differences
27. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
28. Menstrual cycle effects on caffeine elimination in the human female
29. Intersubject and dose-related variability after intravenous administration of erythromycin
30. Effect of age and gender on the activity of human hepatic cyp3A
31. Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women
32. Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe
33. Do alcohol pharmacokinetics in women vary due to the menstrual cycle
34. The influence of the menstrual cycle on triazolam and indocyanine green pharmacokinetics
35. Neuroendocrine control of the menstrual cycle
36. Multiple-dose pharmacokinetics of zidovudine in hemophilia patients with human immunodeficiency virus infection
37. Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases
38. Intravenous and oral pharmacokinetics and coagulation effects of zidovudine in asymptomatic HIV-infected hemophilia patients
39. Clinical pharmacokinetics of zidovudine: Inter- and intraindividual variability and relationship to long term efficacy and toxicity
40. Concentration controlled zidovudine therapy
41. Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus
42. Drug interactions with antiviral drugs
43. P450 enzymes of estrogen metabolism
44. Mechanism of estrogen-imipramine interaction
45. Interactions of hepatic cytochromees P450 with steroidal hormones
46. Pathway-sensitive sex differences in the metabolic clearance of propranolol in human subjects
47. Influence of sex and oral contraceptive steroids on paracetamol metabolism
48. Antimicrobial agents